Literature DB >> 7917682

Early release of glycogen phosphorylase in patients with unstable angina and transient ST-T alterations.

J Mair1, B Puschendorf, J Smidt, P Lechleitner, F Dienstl, F Noll, E G Krause, G Rabitzsch.   

Abstract

OBJECTIVE: To determine whether transient ST-T alterations in patients with unstable angina are associated with an increase in plasma glycogen phosphorylase BB concentrations on admission to hospital.
DESIGN: Prospective screening of patients with unstable angina for markers of myocardial cell damage.
SETTING: Accident and emergency department of university hospital. PATIENTS: 48 consecutive patients admitted for angina pectoris (18 with transient ST-T alterations). None of the patients had acute myocardial infarction according to standard criteria. MAIN OUTCOME MEASURES: Creatine kinase and creatine kinase MB activities, creatine kinase MB mass concentration, and myoglobin, cardiac troponin T, and glycogen phosphorylase BB concentrations on admission.
RESULTS: All variables except for creatine kinase and creatine kinase MB activities were significantly higher on admission in patients with unstable angina and transient ST-T alterations than in patients without. However, glycogen phosphorylase BB concentration was the only marker that was significantly (p = 0.0001) increased above its discriminator value in most patients (16). In the 18 patients with transient ST-T alterations creatine kinase MB mass concentration and troponin T and myoglobin concentrations were significantly (p = 0.0001) less commonly increased on admission (in five, three, and two patients, respectively).
CONCLUSIONS: The early release of glycogen phosphorylase BB may help to identify high risk patients with unstable angina even on admission to an emergency department. Glycogen phosphorylase BB concentrations could help to guide decisions about patient management.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917682      PMCID: PMC1025473          DOI: 10.1136/hrt.72.2.125

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  21 in total

1.  ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome.

Authors:  A Langer; M R Freeman; P W Armstrong
Journal:  J Am Coll Cardiol       Date:  1989-06       Impact factor: 24.094

2.  Association of gylcogenolysis with cardiac sarcoplasmic reticulum.

Authors:  M L Entam; K Kanike; M A Goldstein; T E Nelson; E P Bornet; T W Futch; A Schwartz
Journal:  J Biol Chem       Date:  1976-05-25       Impact factor: 5.157

3.  Human brain glycogen phosphorylase. Cloning, sequence analysis, chromosomal mapping, tissue expression, and comparison with the human liver and muscle isozymes.

Authors:  C B Newgard; D R Littman; C van Genderen; M Smith; R J Fletterick
Journal:  J Biol Chem       Date:  1988-03-15       Impact factor: 5.157

4.  Association of glycogenolysis with cardiac sarcoplasmic reticulum: II. Effect of glycogen depletion, deoxycholate solubilization and cardiac ischemia: evidence for a phorphorylase kinase membrane complex.

Authors:  M L Entman; E P Bornet; W B Van Winkle; M A Goldstein; A Schwartz
Journal:  J Mol Cell Cardiol       Date:  1977-07       Impact factor: 5.000

5.  Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.

Authors:  E Falk
Journal:  Circulation       Date:  1985-04       Impact factor: 29.690

6.  Creatine kinase and phosphorylase in cardiac lymph: coronary occlusion and reperfusion.

Authors:  L H Michael; J R Hunt; D Weilbaecher; M B Perryman; R Roberts; R M Lewis; M L Entman
Journal:  Am J Physiol       Date:  1985-03

7.  Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death.

Authors:  M J Davies; A C Thomas; P A Knapman; J R Hangartner
Journal:  Circulation       Date:  1986-03       Impact factor: 29.690

8.  Myoglobin, creatine kinase-B isoenzyme, and myosin light chain release in patients with unstable angina pectoris.

Authors:  E Hoberg; H A Katus; K W Diederich; W Kübler
Journal:  Eur Heart J       Date:  1987-09       Impact factor: 29.983

9.  Human brain-type glycogen phosphorylase: quantitative localization in human tissues determined with an immunoassay system.

Authors:  K Kato; A Shimizu; N Kurobe; M Takashi; T Koshikawa
Journal:  J Neurochem       Date:  1989-05       Impact factor: 5.372

10.  Immunenzymometric assay for the heart specific glycogen phosphorylase BB in human serum using monoclonal antibodies.

Authors:  U Hofmann; G Rabitzsch; K Löster; W Handschack; F Noll; E G Krause
Journal:  Biomed Biochim Acta       Date:  1989
View more
  4 in total

Review 1.  Glycogen phosphorylase isoenzyme BB in diagnosis of myocardial ischaemic injury and infarction.

Authors:  E G Krause; G Rabitzsch; F Noll; J Mair; B Puschendorf
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

2.  Can clonidine, enoximone, and enalaprilat help to protect the myocardium against ischaemia in cardiac surgery?

Authors:  J Boldt; G Rothe; E Schindler; C Döll; G Görlach; G Hempelmann
Journal:  Heart       Date:  1996-09       Impact factor: 5.994

3.  Biochemical markers of myocardial injury.

Authors:  P K Nigam
Journal:  Indian J Clin Biochem       Date:  2007-03

4.  Quick identification of acute chest pain patients study (QICS).

Authors:  Hendrik M Willemsen; Gonda de Jong; René A Tio; Wybe Nieuwland; Ido P Kema; Iwan C C van der Horst; Mattijs Oudkerk; Felix Zijlstra
Journal:  BMC Cardiovasc Disord       Date:  2009-06-15       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.